Suggestions
Martin Kotev
Computational Chemist, PhD, Computational Drug Design, Principal Scientist/Team Leader/Molecular Architects - Evotec
Martin Kotev is a Principal Scientist in the Molecular Architects team at Evotec, specializing in computational chemistry and drug design. With over 20 years of experience in the field, he has contributed significantly to the development of methodologies for drug discovery, particularly through the use of quantum mechanics and molecular dynamics simulations.
Kotev holds a PhD and has been involved in various research projects, including the application of high-performance computing for drug discovery. He has published extensively, with over 60 publications in the area of computational drug design, highlighting his expertise in the field.1234
His educational background includes studies at the Bulgarian Academy of Sciences, which laid the foundation for his career in computational chemistry.2
